Skip to search formSkip to main contentSkip to account menu

BMY 45778

Known as: BMY-45778 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

AcetatesAcetic Acid EstersOxazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells.
2001
2001
Prostacyclin receptor‐independent inhibition of phospholipase C activity by non‐prostanoid prostacyclin mimetics
Chinese hamster ovary (CHO) cells were transiently transfected with the mouse prostacyclin (mIP) receptor to examine IP agonist… 
1999
1999
Characterization of chimeric prostacyclin/prostaglandin D(2) receptors.
1997
1997
[3-[4-(4,5-Diphenyl-2-oxazolyl)-5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)